Recruiting studies: Central Line Associated Blood Stream Infections Clabsi

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Rece
Phase 3 · 22 location(s) · CorMedix · NCT06822426 CLABSI Prevention With Tissue Adhesive
NA · 1 location(s) · Rabin Medical Center · NCT05721677 Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
NA · 19 location(s) · Swedish Medical Center · NCT07108660

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.